The effect of cognitive decline on the medication adherence in patients with type II diabetes mellitus
DOI:
https://doi.org/10.46542/pe.2024.242.163171Keywords:
Cognitive decline, Diabetes mellitus, Medical adherenceAbstract
Background: Type II Diabetes Mellitus (T2DM) is a risk factor for decreased cognitive function that is rarely recognised by patients, apart from age and other factors.
Objective: This study aims to assess the effect of decreased cognitive function on medication adherence in T2DM patients.
Method: This study used a cross-sectional design conducted at the Pasar Minggu Community Health Center, Jakarta, Indonesia. Cognitive function was assessed using the validated Indonesian version of the Montreal Cognitive Assessment (MoCA-Ina) questionnaire.
Results: One hundred twenty-seven T2DM patients (75.6% female) with a mean age of 58.69 years were recruited. The proportion of T2DM patients with decreased cognitive function was quite high, namely 61%. The proportion of non-adherent patients in the group with decreased cognitive function (70.6%) was greater than in the normal group (29.4%). Decreased cognitive function significantly affected non-adherence in taking medication with aOR 3.744 (95% CI 1.485–9.442), p = 0.005, after controlling for age, education level, HbA1c value, and comorbid dyslipidemia.
Conclusion: Patients with decreased cognitive function are 3.7 times more likely to be non-compliant with medication, regardless of age, education level, HbA1c value, and dyslipidemia. Special management is needed for T2DM patients with decreased cognitive function, such as caregiver assistance, education by pharmacists, and simpler drug regimes.
References
Anghel, L. A., Farcas, A. M., & Oprean, R. N. (2019). An overview of the common methods used to measure treatment adherence. Medicine and Pharmacy Reports, 92(2), 117–122. https://doi.org/10.15386/mpr-1201
Biessels, G. J., Nobili, F., Teunissen, C. E., Simó, R., & Scheltens, P. (2021). Series diabetes and brain health 3 Understanding multifactorial brain changes in type 2 diabetes: A biomarker perspective, 19(August 2020). https://doi.org/10.1016/S1474-4422(20)30139-3
Cahyadi, H., Prayitno, A., & Setiawan, E. (2015). Reliability and validity ff Adherence to Refill and Medication Scale (ARMS) in Indonesian geriatric population with diabetes. IAGG Asia/Oceania 2015. Retrieved April 14, 2021, from http://repository.ubaya.ac.id/id/eprint/34101
Cain, C. J., Meisman, A. R., Drucker, K., Isaac, E. I., Verma, T., Gri, J., & Rohan, J. M. (2020). When multiple objective measures of Mmedication adherence indicate incongruent adherence results : An example with pediatric cancer. International Journal of Environmental Research and Public Health, 17, 1–8. https://doi.org/doi:10.3390/ijerph17061956
Capoccia, K., Odegard, P. S., & Letassy, N. (2016). Medication adherence with diabetes medication, 42(1), 34–71. https://doi.org/10.1177/0145721715619038
Chudiak, A., Uchmanowicz, I., & Mazur, G. (2018). Relation between cognitive impairment and treatment adherence in elderly hypertensive patients. Clinical Interventions in Aging, 13, 1409–1418. https://doi.org/10.2147/CIA.S162701
Forbes, C. A., Deshpande, S., Sorio-vilela, F., Kutikova, L., Duffy, S., Gouni-berthold, I., … Hagström, E. (2018). A systematic literature review comparing methods for the measurement of patient persistence and adherence. Current Medical Research and Opinion, 34(9), 1613–1625. https://doi.org/10.1080/03007995.2018.1477747
Ginting, H., Näring, G., Veld, W. M. Van Der, & Srisayekti, W. (2013). Validating the Beck Depression Inventory-II in Indonesia ’ s general population and coronary heart disease patients. International Journal of Clinical and Health Psychology, 13(3), 235–242. https://doi.org/10.1016/S1697-2600(13)70028-0
Gordon, J., Mcewan, P., Idris, I., Evans, M., & Puelles, J. (2018). Treatment choice , medication adherence and glycemic efficacy in people with type 2 diabetes : a UK clinical practice database study. BMJ Open, 1–9. https://doi.org/10.1136/bmjdrc-2018-000512
Groeneveld, O. N., van den Berg, E., Rutten, G. E. H. M., Koekkoek, P. S., Kappelle, L. J., & Biessels, G. J. (2018). Applicability of diagnostic constructs for cognitive impairment in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 142, 92–99. https://doi.org/10.1016/j.diabres.2018.05.025
Hayes, T. L., Larimer, N., Adami, A., & Kaye, J. A. (2010). Medication adherence in healthy elders: Small cognitive changes make a big difference. Aging Health, 21(4), 567–580. https://doi.org/10.1177/0898264309332836
Hosmer, D. W., Lameshow, S., & Sturdivant, R. X. (2013). Applied logistic regression. John Wiley & Sons, Incorporated, USA.
Husein, N., Lumempouw, S., & Ramli, Y. (2010). Uji validitas dan reliabilitas Monreal Cognitive Assessment Versi Indonesia (MoCA-Ina ). Neurona, 27(4).
Kirkpatrick, A. C., Vincent, A. S., Guthery, L., & Prodan, C. I. (2014). Cognitive impairment is associated with medication nonadherence in asymptomatic carotid stenosis. American Journal of Medicine, 127(12), 1243–1246. https://doi.org/10.1016/j.amjmed.2014.08.010
Koekkoek, P. S., Kappelle, L. J., van den Berg, E., Rutten, G. E. H. M., & Biessels, G. J. (2015). Cognitive function in patients with diabetes mellitus: Guidance for daily care. The Lancet Neurology, 14(3), 329–340. https://doi.org/10.1016/S1474-4422(14)70249-2
Kripalani, S., Risser, J., Gatti, M. E., & Jacobson, T. A. (2009). Development and evaluation of the Adherence to Refills and Medications Scale ( ARMS ) among low-literacy patients with chronic disease. Value in Health, 12(1), 118–123. https://doi.org/10.1111/j.1524-4733.2008.00400.x
Lee, C. S., Tan, J. H. M., Sankari, U., Koh, Y. L. ileen, & Tan, N. C. (2017). Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: A cross- sectional study. BMJ Open, 7(9), 1–7. https://doi.org/10.1136/bmjopen-2017-016317
Lin, L., Sun, Y., Heng, B. H., & Chew, D. E. K. (2017). Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open, 5, 1–9. https://doi.org/10.1136/bmjdrc-2017-000429
Lövdén, M., Fratiglioni, L., Glymour, M. M., Lindenberger, U., & Tucker-Drob, E. M. (2020). Education and cognitive functioning across the life span. Psychological Science in the Public Interest, 21(1), 6–41. https://doi.org/10.1177/1529100620920576
Low, S., Ng, T. P., Lim, C. L., Wang, J., Moh, A., Ang, S. F., … Lim, S. C. (2020). Association between vascular measures and cognitive function in type 2 diabetes. Journal of Diabetes and Its Complications, 34(12), 107724. https://doi.org/10.1016/j.jdiacomp.2020.107724
Morley, J. E., Morris, J. C., Berg-weger, M., Carpenter, B. D., Dubois, B., Fitten, L. J., … Kong, H. (2016). Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference. J Am Med Dir Assoc, 16(9), 731–739. https://doi.org/10.1016/j.jamda.2015.06.017.
Munshi, M. N. (2017). Cognitive dysfunction in older adults with diabetes: What a clinician needs to know. Diabetes Care, 40(4), 461–467. https://doi.org/10.2337/dc16-1229
Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., … Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA : A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Ogston, S. A., Lemeshow, S., Hosmer, D. W., Klar, J., & Lwanga, S. K. (1991). Adequacy of sample size in health studies. Biometrics, 47(1), 347. https://doi.org/10.2307/2532527
Pandey, A., Raza, F., Velasco, A., Brinker, S., Ayers, C., Das, S. R., … Vongpatanasin, W. (2015). Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment – Resistant hypertension. Journal of the American Society of Hypertension, 9(6), 420–426. https://doi.org/10.1016/j.jash.2015.04.004
Polonsky, W. H., & Henry, R. R. (2016). Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Dove Press, 10, 1299–1307. https://doi.org/10.2147/PPA.S106821
Rohde, D., Gaynor, E., Large, M., Mellon, L., Bennett, K., Williams, J., … Hickey, A. (2019). Cognitive impairment and medication adherence post-stroke: A five-year follow-up of the ASPIRE-S cohort. Journal Plos One, 14(10), 1–15. https://doi.org/10.1371/journal.pone.0223997
Shen, L., Tang, X., Li, C., Qian, Z., Wang, J., & Liu, W. (2021). Status and factors of cognitive function among older adults. Frontiers in Psychology, 12(September), 1–9. https://doi.org/10.3389/fpsyg.2021.728165
Smith, D., Lovell, J., Weller, C., Kennedy, B., Winbolt, M., Young, C., & Ibrahim, J. (2017). A systematic review of medication nonadherence in persons with dementia or cognitive impairment. PLoS ONE, 12(2), 1–19. https://doi.org/10.1371/journal.pone.0170651
Soraya, I. A., Sauriasari, R., Prawiroharjo, P., & Risni, H. W. (2022). The association between adherence to oral antihyperglycemic agent and HbA1c level. Pharmaceutical Sciences and Research, 9(2), 93–101. https://doi.org/10.7454/psr.v9i2.1260
Xiang, Q., Zhang, J., Li, C., Wang, Y., Zeng, M., Cai, Z., … Li, X. (2021). Neuropeptides insulin resistance-induced hyperglycemia decreased the activation of Akt / CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction. YNPEP, 54(2015), 9–15. https://doi.org/10.1016/j.npep.2015.08.009
Xu, N., Xie, S., Chen, Y., Li, J., & Sun, L. (2020). Factors Influencing medication non-adherence among Chinese older adults with diabetes mellitus. International Journal of Environment Research and Public Health, 17(6012), 1–10. https://doi.org/10.3390/ijerph17176012
Xue, M., Xu, W., Ou, Y., Cao, X., Tan, M., Tan, L., & Yu, J. (2019). Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Research Reviews, 55, 1–9. https://doi.org/10.1016/j.arr.2019.100944
